Jansen TL - Search Results

1

Emerging and New Treatment Options for Knee Osteoarthritis.

Siddiq MAB, Clegg D, Jansen TL, Rasker JJ. Siddiq MAB, et al. Among authors: jansen tl. Curr Rheumatol Rev. 2022;18(1):20-32. doi: 10.2174/1573397117666211116111738. Curr Rheumatol Rev. 2022. PMID: 34784876 Review.

2

Therapeutic consequences of crystals in the synovial fluid: a review for clinicians.

Jansen TL, Rasker JJ. Jansen TL, et al. Clin Exp Rheumatol. 2011 Nov-Dec;29(6):1032-9. Epub 2011 Dec 22. Clin Exp Rheumatol. 2011. PMID: 22133072 Review.

3

Valuable verities on vitamin D.

Jansen TL, Rasker JJ. Jansen TL, et al. Int J Rheum Dis. 2016 Apr;19(4):329-31. doi: 10.1111/1756-185X.12894. Int J Rheum Dis. 2016. PMID: 27122194 No abstract available.

4

Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study.

Giesen T, Sanduleanu S, Jansen TLTA. Giesen T, et al. Clin Rheumatol. 2022 Jun;41(6):1833-1841. doi: 10.1007/s10067-022-06073-7. Epub 2022 Feb 2. Clin Rheumatol. 2022. PMID: 35107653

5

What is the Place for Uricosuric Agents in Gout Management?

Siddiq MAB, Jansen TL, Rasker JJ. Siddiq MAB, et al. Among authors: jansen tl. Curr Rheumatol Rev. 2022;18(4):279-285. doi: 10.2174/1573397118666220308160124. Curr Rheumatol Rev. 2022. PMID: 35260069 No abstract available.

6

Measuring Disease Exacerbation and Flares in Rheumatoid Arthritis: Comparison of Commonly Used Disease Activity Indices and Individual Measures.

Voshaar MAHO, Moghadam MG, Vonkeman HE, Ten Klooster PM, van Schaardenburg D, Tekstra J, Visser H, van de Laar MAFJ, Jansen TL. Voshaar MAHO, et al. Among authors: jansen tl. J Rheumatol. 2017 Aug;44(8):1118-1124. doi: 10.3899/jrheum.160915. Epub 2017 May 15. J Rheumatol. 2017. PMID: 28507187

7

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.

Janssen CA, Jansen TLTA, Oude Voshaar MAH, Vonkeman HE, van de Laar MAFJ. Janssen CA, et al. Rheumatol Int. 2017 Sep;37(9):1435-1440. doi: 10.1007/s00296-017-3777-3. Epub 2017 Jul 26. Rheumatol Int. 2017. PMID: 28748426 Free PMC article.

8

Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity.

Lamers-Karnebeek FBG, Jacobs JWG, Radstake TRDJ, van Riel PLCM, Jansen TL. Lamers-Karnebeek FBG, et al. Among authors: jansen tl. Rheumatology (Oxford). 2019 Mar 1;58(3):427-431. doi: 10.1093/rheumatology/key292. Rheumatology (Oxford). 2019. PMID: 30383251

9

A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties.

Janssen CA, Oude Voshaar MAH, Ten Klooster PM, Jansen TLTA, Vonkeman HE, van de Laar MAFJ. Janssen CA, et al. Health Qual Life Outcomes. 2019 Apr 11;17(1):63. doi: 10.1186/s12955-019-1125-x. Health Qual Life Outcomes. 2019. PMID: 30975212 Free PMC article.

10

A historical journey of searching for uricosuric drugs.

Jansen TL, Tanja G, Matthijs J. Jansen TL, et al. Clin Rheumatol. 2022 Jan;41(1):297-305. doi: 10.1007/s10067-021-05930-1. Epub 2021 Sep 28. Clin Rheumatol. 2022. PMID: 34581891 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters